Instituto Oncológico Dr. Rosell

Barcelona 8028

0 studies enrolling now · 3 studies all time

What they study most

Adjuvant, Advanced Melanoma, EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, Metastatic Colorectal Cancer, NSCLC, Stage IB-IIIA, Post-surgical, Uncommon EGFR Mutations

Studies at this site

• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma. — Completed
• A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer — Stopped early